Skip to main content
Paulo Garcia, MD, Pathology, Pittsburgh, PA

PauloSaldiGarciaMDFCAP, FASCP, FUSCAP

Pathology Pittsburgh, PA

Cytopathology, Gastrointestinal & Hepatobiliary Pathology, Anatomic Pathology, Clinical Pathology

Clinical Assistant Professor

Dr. Garcia is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Garcia's full profile

Already have an account?

  • Office

    UPMC Passavant
    9100 Babcock Blvd
    Pittsburgh, PA 15237
    Phone+1 412-748-3233

Summary

  • Dr. Paulo Garcia is a board-certified pathologist in Pittsburgh, PA. He received his medical degree from University of Nevada School of Medicine and has been in practice 2 years. He specializes in cytopathology, GI & hepatobiliary pathology, pancreaticobiliary pathology, anatomic pathology, and clinical pathology.

Education & Training

  • Virginia Commonwealth University Health System
    Virginia Commonwealth University Health SystemFellowship, Cytopathology, 2020 - 2021
  • Virginia Commonwealth University Health System
    Virginia Commonwealth University Health SystemResidency, Pathology-Anatomic and Clinical, 2016 - 2020
  • University of Nevada, Reno School of Medicine
    University of Nevada, Reno School of MedicineClass of 2016

Certifications & Licensure

  • PA State Medical License
    PA State Medical License 2021 - 2024
  • VA State Medical License
    VA State Medical License 2020 - 2022
  • American Board of Pathology Pathology - Anatomic/Pathology - Clinical

Publications & Presentations

PubMed

Press Mentions

  • Area 23: Lil Sugar, the Villain Protecting Kids’ Health
    Area 23: Lil Sugar, the Villain Protecting Kids’ HealthOctober 6th, 2021
  • Accelerating the Pace of Engineered Cell Therapies, from Lab to Bedside
    Accelerating the Pace of Engineered Cell Therapies, from Lab to BedsideMay 6th, 2021
  • Greg Crescenzi Joins Kytopen as Chief Commercial Officer to Drive Discovery, Development and Delivery of Curative Cellular Therapeutics
    Greg Crescenzi Joins Kytopen as Chief Commercial Officer to Drive Discovery, Development and Delivery of Curative Cellular TherapeuticsMarch 30th, 2021
  • Join now to see all